Drs Kitko and Patel discuss graft-versus-host disease recognition, treatment selection, and ongoing research with novel agents and biomarkers of response.
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb's Application for Orencia for the Prevention of Acute Graft Versus Host Disease investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.